APO Research
Talk to an analyst

APO RESEARCH · REPORT

Systemic Mastocytosis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Systemic Mastocytosis Treatment Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchSystemic Mastocytosis Treatment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Systemic Mastocytosis Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Systemic Mastocytosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Systemic Mastocytosis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Systemic Mastocytosis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Systemic Mastocytosis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Systemic Mastocytosis Treatment include Novartis AG, AbbVie Inc, Stemline Therapeutics Inc, Seattle Genetics Inc, Patara Pharma Inc, Deciphera Pharmaceuticals LLC, Bristol-Myers Squibb Company, Blueprint Medicines Corp and Arog Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Systemic Mastocytosis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Systemic Mastocytosis Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Systemic Mastocytosis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Systemic Mastocytosis Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Systemic Mastocytosis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Systemic Mastocytosis Treatment Market by Company

Novartis AG

AbbVie Inc

Stemline Therapeutics Inc

Seattle Genetics Inc

Patara Pharma Inc

Deciphera Pharmaceuticals LLC

Bristol-Myers Squibb Company

Blueprint Medicines Corp

Arog Pharmaceuticals Inc

AB Science SA

Systemic Mastocytosis Treatment Segment by Type

Cromolyn Sodium

Brentuximab Vedotin

Crenolanib Besylate

BLU-285

AK-002

Others

Systemic Mastocytosis Treatment Segment by Application

Homecare

Hospital

Clinic

Systemic Mastocytosis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Mastocytosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Systemic Mastocytosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Mastocytosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Systemic Mastocytosis Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Systemic Mastocytosis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cromolyn Sodium Table 2. Major Company of Brentuximab Vedotin Table 3. Major Company of Crenolanib Besylate Table 4. Major Company of BLU-285 Table 5. Major Company of AK-002 Table 6. Major Company of Others Table 7. Global Systemic Mastocytosis Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 9. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Type (2021-2026) Table 10. Global Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 11. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Type (2021-2026) Table 12. Global Systemic Mastocytosis Treatment Price by Type (2021-2026) & (US$/unit) Table 13. Global Systemic Mastocytosis Treatment Sales by Type (2027-2032) & (k units) Table 14. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Type (2027-2032) Table 15. Global Systemic Mastocytosis Treatment Sales by Type (2027-2032) & (US$ Million) Table 16. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Type (2027-2032) Table 17. Global Systemic Mastocytosis Treatment Price by Type (2027-2032) & (US$/unit) Table 18. North America Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 19. North America Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 21. Europe Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 25. Latin America Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (US$ Million) Table 28. Systemic Mastocytosis Treatment Industry Trends Table 29. Systemic Mastocytosis Treatment Industry Drivers Table 30. Systemic Mastocytosis Treatment Industry Opportunities and Challenges Table 31. Systemic Mastocytosis Treatment Industry Restraints Table 32. Global Systemic Mastocytosis Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Systemic Mastocytosis Treatment Revenue Market Share by Company (2021-2026) Table 34. Global Systemic Mastocytosis Treatment Sales by Company (2021-2026) & (k units) Table 35. Global Systemic Mastocytosis Treatment Sales Share by Company (2021-2026) Table 36. Global Systemic Mastocytosis Treatment Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Systemic Mastocytosis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Systemic Mastocytosis Treatment Major Company Production Sites and Headquarters Table 39. Global Systemic Mastocytosis Treatment Company, Product Type & Application Table 40. Global Systemic Mastocytosis Treatment Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Systemic Mastocytosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Systemic Mastocytosis Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Systemic Mastocytosis Treatment Sales by Region (2021-2026) & (k units) Table 45. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Region (2021-2026) Table 46. Global Systemic Mastocytosis Treatment Sales by Region (2021-2026) & (US$ Million) Table 47. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Region (2021-2026) Table 48. Global Systemic Mastocytosis Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Systemic Mastocytosis Treatment Sales by Region (2027-2032) & (k units) Table 50. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Region (2027-2032) Table 51. Global Systemic Mastocytosis Treatment Sales by Region (2027-2032) & (US$ Million) Table 52. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Region (2027-2032) Table 53. Global Systemic Mastocytosis Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Systemic Mastocytosis Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 56. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Application (2021-2026) Table 57. Global Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 58. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Application (2021-2026) Table 59. Global Systemic Mastocytosis Treatment Price by Application (2021-2026) & (US$/unit) Table 60. Global Systemic Mastocytosis Treatment Sales by Application (2027-2032) & (k units) Table 61. Global Systemic Mastocytosis Treatment Sales Market Share in Volume by Application (2027-2032) Table 62. Global Systemic Mastocytosis Treatment Sales by Application (2027-2032) & (US$ Million) Table 63. Global Systemic Mastocytosis Treatment Sales Market Share in Value by Application (2027-2032) Table 64. Global Systemic Mastocytosis Treatment Price by Application (2027-2032) & (US$/unit) Table 65. North America Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 66. North America Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 68. Europe Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 72. Latin America Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Novartis AG Systemic Mastocytosis Treatment Product Portfolio Table 79. Novartis AG Recent Development Table 80. AbbVie Inc Company Information Table 81. AbbVie Inc Business Overview Table 82. AbbVie Inc Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. AbbVie Inc Systemic Mastocytosis Treatment Product Portfolio Table 84. AbbVie Inc Recent Development Table 85. Stemline Therapeutics Inc Company Information Table 86. Stemline Therapeutics Inc Business Overview Table 87. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Portfolio Table 89. Stemline Therapeutics Inc Recent Development Table 90. Seattle Genetics Inc Company Information Table 91. Seattle Genetics Inc Business Overview Table 92. Seattle Genetics Inc Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Seattle Genetics Inc Systemic Mastocytosis Treatment Product Portfolio Table 94. Seattle Genetics Inc Recent Development Table 95. Patara Pharma Inc Company Information Table 96. Patara Pharma Inc Business Overview Table 97. Patara Pharma Inc Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Patara Pharma Inc Systemic Mastocytosis Treatment Product Portfolio Table 99. Patara Pharma Inc Recent Development Table 100. Deciphera Pharmaceuticals LLC Company Information Table 101. Deciphera Pharmaceuticals LLC Business Overview Table 102. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Portfolio Table 104. Deciphera Pharmaceuticals LLC Recent Development Table 105. Bristol-Myers Squibb Company Company Information Table 106. Bristol-Myers Squibb Company Business Overview Table 107. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Portfolio Table 109. Bristol-Myers Squibb Company Recent Development Table 110. Blueprint Medicines Corp Company Information Table 111. Blueprint Medicines Corp Business Overview Table 112. Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Portfolio Table 114. Blueprint Medicines Corp Recent Development Table 115. Arog Pharmaceuticals Inc Company Information Table 116. Arog Pharmaceuticals Inc Business Overview Table 117. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Portfolio Table 119. Arog Pharmaceuticals Inc Recent Development Table 120. AB Science SA Company Information Table 121. AB Science SA Business Overview Table 122. AB Science SA Systemic Mastocytosis Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. AB Science SA Systemic Mastocytosis Treatment Product Portfolio Table 124. AB Science SA Recent Development Table 125. North America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 126. North America Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 127. North America Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2026) Table 128. North America Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032) & (k units) Table 129. North America Systemic Mastocytosis Treatment Sales Market Share Forecast by Country (2027-2032) Table 130. North America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Systemic Mastocytosis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Systemic Mastocytosis Treatment Market Share by Country (2021-2026) Table 133. North America Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Systemic Mastocytosis Treatment Market Share Forecast by Country (2027-2032) Table 135. Europe Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 136. Europe Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 137. Europe Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2026) Table 138. Europe Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032) & (k units) Table 139. Europe Systemic Mastocytosis Treatment Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Systemic Mastocytosis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Systemic Mastocytosis Treatment Market Share by Country (2021-2026) Table 143. Europe Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Systemic Mastocytosis Treatment Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 147. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032) & (k units) Table 149. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Systemic Mastocytosis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Systemic Mastocytosis Treatment Market Share by Country (2021-2026) Table 153. Asia-Pacific Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Systemic Mastocytosis Treatment Market Share Forecast by Country (2027-2032) Table 155. Latin America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. Latin America Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 157. Latin America Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2026) Table 158. Latin America Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032) & (k units) Table 159. Latin America Systemic Mastocytosis Treatment Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Systemic Mastocytosis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Systemic Mastocytosis Treatment Market Share by Country (2021-2026) Table 163. Latin America Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Systemic Mastocytosis Treatment Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 167. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032) & (k units) Table 169. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Systemic Mastocytosis Treatment Market Share by Country (2021-2026) Table 173. Middle East and Africa Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Systemic Mastocytosis Treatment Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Systemic Mastocytosis Treatment Distributors List Table 178. Systemic Mastocytosis Treatment Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Systemic Mastocytosis Treatment Image Figure 2. Global Systemic Mastocytosis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Systemic Mastocytosis Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Systemic Mastocytosis Treatment Sales (2021-2032) & (k units) Figure 5. Cromolyn Sodium Image Figure 6. Global Cromolyn Sodium Sales YoY Growth (2021-2032) & (k units) Figure 7. Brentuximab Vedotin Image Figure 8. Global Brentuximab Vedotin Sales YoY Growth (2021-2032) & (k units) Figure 9. Crenolanib Besylate Image Figure 10. Global Crenolanib Besylate Sales YoY Growth (2021-2032) & (k units) Figure 11. BLU-285 Image Figure 12. Global BLU-285 Sales YoY Growth (2021-2032) & (k units) Figure 13. AK-002 Image Figure 14. Global AK-002 Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Systemic Mastocytosis Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Systemic Mastocytosis Treatment Market Share by Type 2025 VS 2032 Figure 19. North America Systemic Mastocytosis Treatment Sales Market Share in Volume by Type in 2025 Figure 20. North America Systemic Mastocytosis Treatment Sales Market Share in Value by Type in 2025 Figure 21. Europe Systemic Mastocytosis Treatment Sales Market Share in Volume by Type in 2025 Figure 22. Europe Systemic Mastocytosis Treatment Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share in Value by Type in 2025 Figure 25. Latin America Systemic Mastocytosis Treatment Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Systemic Mastocytosis Treatment Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Systemic Mastocytosis Treatment Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Homecare Image Figure 32. Global Homecare Sales YoY Growth (2021-2032) & (k units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Systemic Mastocytosis Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Systemic Mastocytosis Treatment Market Share by Application 2025 VS 2032 Figure 39. North America Systemic Mastocytosis Treatment Sales Market Share in Volume by Application in 2025 Figure 40. North America Systemic Mastocytosis Treatment Sales Market Share in Value by Application in 2025 Figure 41. Europe Systemic Mastocytosis Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Europe Systemic Mastocytosis Treatment Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Systemic Mastocytosis Treatment Sales Market Share in Value by Application in 2025 Figure 45. Latin America Systemic Mastocytosis Treatment Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Systemic Mastocytosis Treatment Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share in Value by Application in 2025 Figure 49. North America Systemic Mastocytosis Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Systemic Mastocytosis Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Systemic Mastocytosis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Systemic Mastocytosis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Systemic Mastocytosis Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Systemic Mastocytosis Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Systemic Mastocytosis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Systemic Mastocytosis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Systemic Mastocytosis Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Systemic Mastocytosis Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Systemic Mastocytosis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Systemic Mastocytosis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Systemic Mastocytosis Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Systemic Mastocytosis Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Systemic Mastocytosis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Systemic Mastocytosis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Systemic Mastocytosis Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Systemic Mastocytosis Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Systemic Mastocytosis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Systemic Mastocytosis Treatment Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Systemic Mastocytosis Treatment Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cromolyn Sodium
  • Brentuximab Vedotin
  • Crenolanib Besylate
  • BLU-285
  • AK-002
  • Others
Applications
  • Homecare
  • Hospital
  • Clinic
Companies covered
  • Novartis AG
  • AbbVie Inc
  • Stemline Therapeutics Inc
  • Seattle Genetics Inc
  • Patara Pharma Inc
  • Deciphera Pharmaceuticals LLC
  • Bristol-Myers Squibb Company
  • Blueprint Medicines Corp
  • Arog Pharmaceuticals Inc
  • AB Science SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Systemic Mastocytosis Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Systemic Mastocytosis Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Systemic Mastocytosis Treatment Market by Type
  6. 1.3.1 Cromolyn Sodium
  7. 1.3.2 Brentuximab Vedotin
  8. 1.3.3 Crenolanib Besylate
  9. 1.3.4 BLU-285
  10. 1.3.5 AK-002
  11. 1.3.6 Others
  12. 1.4 Global Systemic Mastocytosis Treatment Market Size by Type
  13. 1.4.1 Global Systemic Mastocytosis Treatment Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Systemic Mastocytosis Treatment Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Systemic Mastocytosis Treatment Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Systemic Mastocytosis Treatment Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Systemic Mastocytosis Treatment Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Systemic Mastocytosis Treatment Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Systemic Mastocytosis Treatment Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Systemic Mastocytosis Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Systemic Mastocytosis Treatment Industry Trends
  2. 2.2 Systemic Mastocytosis Treatment Industry Drivers
  3. 2.3 Systemic Mastocytosis Treatment Industry Opportunities and Challenges
  4. 2.4 Systemic Mastocytosis Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Systemic Mastocytosis Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Systemic Mastocytosis Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Systemic Mastocytosis Treatment Price (2021-2026)
  4. 3.4 Global Systemic Mastocytosis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Systemic Mastocytosis Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Systemic Mastocytosis Treatment Company, Product Type & Application
  7. 3.7 Global Systemic Mastocytosis Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Systemic Mastocytosis Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Systemic Mastocytosis Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Systemic Mastocytosis Treatment Tier 1, Tier 2, and Tier 3
4 Systemic Mastocytosis Treatment Regional Status and Outlook
  1. 4.1 Global Systemic Mastocytosis Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Systemic Mastocytosis Treatment Historic Market Size by Region
  3. 4.2.1 Global Systemic Mastocytosis Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Systemic Mastocytosis Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Systemic Mastocytosis Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Systemic Mastocytosis Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Systemic Mastocytosis Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Systemic Mastocytosis Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Systemic Mastocytosis Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Systemic Mastocytosis Treatment by Application
  1. 5.1 Systemic Mastocytosis Treatment Market by Application
  2. 5.1.1 Homecare
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Systemic Mastocytosis Treatment Market Size by Application
  6. 5.2.1 Global Systemic Mastocytosis Treatment Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Systemic Mastocytosis Treatment Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Systemic Mastocytosis Treatment Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Systemic Mastocytosis Treatment Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Systemic Mastocytosis Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Systemic Mastocytosis Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Systemic Mastocytosis Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Systemic Mastocytosis Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Systemic Mastocytosis Treatment Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 AbbVie Inc
  8. 6.2.1 AbbVie Inc Company Information
  9. 6.2.2 AbbVie Inc Business Overview
  10. 6.2.3 AbbVie Inc Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Inc Systemic Mastocytosis Treatment Product Portfolio
  12. 6.2.5 AbbVie Inc Recent Developments
  13. 6.3 Stemline Therapeutics Inc
  14. 6.3.1 Stemline Therapeutics Inc Company Information
  15. 6.3.2 Stemline Therapeutics Inc Business Overview
  16. 6.3.3 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Portfolio
  18. 6.3.5 Stemline Therapeutics Inc Recent Developments
  19. 6.4 Seattle Genetics Inc
  20. 6.4.1 Seattle Genetics Inc Company Information
  21. 6.4.2 Seattle Genetics Inc Business Overview
  22. 6.4.3 Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Seattle Genetics Inc Systemic Mastocytosis Treatment Product Portfolio
  24. 6.4.5 Seattle Genetics Inc Recent Developments
  25. 6.5 Patara Pharma Inc
  26. 6.5.1 Patara Pharma Inc Company Information
  27. 6.5.2 Patara Pharma Inc Business Overview
  28. 6.5.3 Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Patara Pharma Inc Systemic Mastocytosis Treatment Product Portfolio
  30. 6.5.5 Patara Pharma Inc Recent Developments
  31. 6.6 Deciphera Pharmaceuticals LLC
  32. 6.6.1 Deciphera Pharmaceuticals LLC Company Information
  33. 6.6.2 Deciphera Pharmaceuticals LLC Business Overview
  34. 6.6.3 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Portfolio
  36. 6.6.5 Deciphera Pharmaceuticals LLC Recent Developments
  37. 6.7 Bristol-Myers Squibb Company
  38. 6.7.1 Bristol-Myers Squibb Company Company Information
  39. 6.7.2 Bristol-Myers Squibb Company Business Overview
  40. 6.7.3 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 6.8 Blueprint Medicines Corp
  44. 6.8.1 Blueprint Medicines Corp Company Information
  45. 6.8.2 Blueprint Medicines Corp Business Overview
  46. 6.8.3 Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Portfolio
  48. 6.8.5 Blueprint Medicines Corp Recent Developments
  49. 6.9 Arog Pharmaceuticals Inc
  50. 6.9.1 Arog Pharmaceuticals Inc Company Information
  51. 6.9.2 Arog Pharmaceuticals Inc Business Overview
  52. 6.9.3 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Portfolio
  54. 6.9.5 Arog Pharmaceuticals Inc Recent Developments
  55. 6.10 AB Science SA
  56. 6.10.1 AB Science SA Company Information
  57. 6.10.2 AB Science SA Business Overview
  58. 6.10.3 AB Science SA Systemic Mastocytosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AB Science SA Systemic Mastocytosis Treatment Product Portfolio
  60. 6.10.5 AB Science SA Recent Developments
7 North America by Country
  1. 7.1 North America Systemic Mastocytosis Treatment Sales by Country
  2. 7.1.1 North America Systemic Mastocytosis Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Systemic Mastocytosis Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Systemic Mastocytosis Treatment Market Size by Country
  6. 7.2.1 North America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Systemic Mastocytosis Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Systemic Mastocytosis Treatment Sales by Country
  2. 8.1.1 Europe Systemic Mastocytosis Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Systemic Mastocytosis Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Systemic Mastocytosis Treatment Market Size by Country
  6. 8.2.1 Europe Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Systemic Mastocytosis Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Systemic Mastocytosis Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Systemic Mastocytosis Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Systemic Mastocytosis Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Systemic Mastocytosis Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Systemic Mastocytosis Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Systemic Mastocytosis Treatment Sales by Country
  2. 10.1.1 South America Systemic Mastocytosis Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Systemic Mastocytosis Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Systemic Mastocytosis Treatment Market Size by Country
  6. 10.2.1 South America Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Systemic Mastocytosis Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Systemic Mastocytosis Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Systemic Mastocytosis Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Systemic Mastocytosis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Systemic Mastocytosis Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Systemic Mastocytosis Treatment Value Chain Analysis
  2. 12.1.1 Systemic Mastocytosis Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Systemic Mastocytosis Treatment Production Mode & Process
  7. 12.2 Systemic Mastocytosis Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Systemic Mastocytosis Treatment Distributors
  10. 12.2.3 Systemic Mastocytosis Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst